Lea Matsuoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lea Matsuoka has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Sophoclis P. Alexopoulos
Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University, Nashville, TN, USA
2 shared publicationsPranit Chotai
Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
1 shared publicationShu Cao
Division of Preventive Medicine, Keck School of Medicine at University of Southern California, Los Angeles, CA, USA
1 shared publicationSusan Groshen
Division of Preventive Medicine, Keck School of Medicine at University of Southern California, Los Angeles, CA, USA
1 shared publicationSuzie Lee
Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University, Nashville, TN, USA
1 shared publication
Latest Publications
- 1 July 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (6) , 2002-2008
Identifying Predictors of Outcomes in Combined Heart and Liver Transplantation
- 1 July 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (6) , 2002-2008
Identifying Predictors of Outcomes in Combined Heart and Liver Transplantation
- 1 April 2019
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 24 (2) , 118-120
Reassessing the role of liver transplantation for patients with metastatic colorectal cancer to the liver
Purpose of review: Early studies reported poor survival rates following liver transplantation for metastatic colorectal cancer to the liver and liver transplantation has thus traditionally been contraindicated for these patients. However, improvements in liver transplantation outcomes, immunosuppression and the treatment of colorectal cancer warrant a reassessment of the role of liver transplantation for metastatic colorectal cancer. Recent findings: The literature on this topic is sparse, the majority of publications being isolated cases of liver transplantation for patients with metastatic colorectal cancer to the liver. These case reports are heterogeneous, as patients received varying chemotherapy regimens and liver transplantation was performed at different times and for different indications. A prospective clinical trial out of Norway, however, has recently reported 5-year survival of 60% in a cohort of 21 patients undergoing liver transplantation for metastatic colorectal cancer to the liver. These results are significantly better than standard of care chemotherapy and comparable with outcomes for other indications for liver transplantation. Summary: The role of liver transplantation for patients with metastatic colorectal cancer to the liver needs to be further elucidated and defined by ongoing clinical trials and experience with living donor liver transplantation.
- 1 April 2019
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 24 (2) , 118-120
Reassessing the role of liver transplantation for patients with metastatic colorectal cancer to the liver
Purpose of review: Early studies reported poor survival rates following liver transplantation for metastatic colorectal cancer to the liver and liver transplantation has thus traditionally been contraindicated for these patients. However, improvements in liver transplantation outcomes, immunosuppression and the treatment of colorectal cancer warrant a reassessment of the role of liver transplantation for metastatic colorectal cancer. Recent findings: The literature on this topic is sparse, the majority of publications being isolated cases of liver transplantation for patients with metastatic colorectal cancer to the liver. These case reports are heterogeneous, as patients received varying chemotherapy regimens and liver transplantation was performed at different times and for different indications. A prospective clinical trial out of Norway, however, has recently reported 5-year survival of 60% in a cohort of 21 patients undergoing liver transplantation for metastatic colorectal cancer to the liver. These results are significantly better than standard of care chemotherapy and comparable with outcomes for other indications for liver transplantation. Summary: The role of liver transplantation for patients with metastatic colorectal cancer to the liver needs to be further elucidated and defined by ongoing clinical trials and experience with living donor liver transplantation.
- 1 April 2018
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 28 (2) , 131-141
Surgical Management of Pancreatic Pseudocysts
- 1 April 2018
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 28 (2) , 131-141
Surgical Management of Pancreatic Pseudocysts